Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Healthy Adult Participants × Omeprazole × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Healthy Adult Participants 1 Chemotherapy Effect 1

Interventions

vorasidenib 1 repaglinide 1 Rosuvastatin Calcium 1 Omeprazole 1 Midazolam 1 Flurbiprofen 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Servier

Phase 1 Completed

Healthy Adult Participants

Data powered by HemOnc (CC BY 4.0) Colophon ⚡